SELLAS Life Sciences

$8.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.24 (-2.87%) Today
+$0.31 (+3.81%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SLS and other stocks, options, and ETFs commission-free!

About SLS

SELLAS Life Sciences Group, Inc. engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and ct-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY. The listed name for SLS is SELLAS Life Sciences Group, Inc. Common Stock.

CEO
Angelos M. Stergiou
Employees
5
Headquarters
New York, New York
Founded
2006
Market Cap
109.61M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
772.33K
High Today
$8.68
Low Today
$7.88
Open Price
$8.57
Volume
358.14K
52 Week High
$19.38
52 Week Low
$1.46

SLS Earnings

-$2.90
-$1.93
-$0.97
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, After Hours

You May Also Like

NUZE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure